BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18074593)

  • 1. [Ulcerative colitis].
    Tada M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():512-5. PubMed ID: 18074593
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conservative therapy of ulcerative colitis--long-term experience].
    Kölbel C; Goebell H
    Internist (Berl); 1991 Sep; 32(9):530-9. PubMed ID: 1683664
    [No Abstract]   [Full Text] [Related]  

  • 3. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of ulcerative hemorrhaging colitis with immunosuppressive drugs].
    Maleev A; Stoianov S; Sirakov P
    Vutr Boles; 1972; 11(3):123-5. PubMed ID: 4154528
    [No Abstract]   [Full Text] [Related]  

  • 5. An unusual complication of immunosuppressive therapy in inflammatory bowel disease.
    Khatchatourian M; Seaton TL
    Am J Gastroenterol; 1997 Sep; 92(9):1558-60. PubMed ID: 9317088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy of ulcerative colitis].
    Rückert Y
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive treatment of ulcerative colitis].
    Shiratori T; Katsumata S; Miyaoka M; Saito T
    Nihon Rinsho; 1999 Nov; 57(11):2486-9. PubMed ID: 10572417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of inflammatory bowel disease, including use of immunosuppressive agents.
    Korelitz BI
    Clin Gastroenterol; 1980 May; 9(2):331-49. PubMed ID: 6104550
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatitis in inflammatory bowel diseases.
    Pitchumoni CS; Rubin A; Das K
    J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Crohn disease and ulcerative colitis--newer therapeutic approaches].
    Ewe K
    Z Gastroenterol; 1993 Feb; 31(2):151-5. PubMed ID: 8096666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and usefulness of mercaptopurine in azathioprine-intolerant Japanese patients with ulcerative colitis.
    Kuriyama M; Kato J; Suzuki H; Akita M; Hiraoka S; Okada H; Yamamoto K
    Dig Endosc; 2010 Oct; 22(4):289-96. PubMed ID: 21175481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematemesis due to Drug Allergy to Oral Prednisolone in a Patient with Ulcerative Colitis.
    Arisaka T; Kanazawa M; Tominaga K; Takahashi F; Takenaka K; Sugaya T; Arisaka O; Irisawa A; Hiraishi H
    Intern Med; 2019 Apr; 58(8):1093-1096. PubMed ID: 30568137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come.
    Peppercom MA
    Am J Gastroenterol; 1996 Sep; 91(9):1689-90. PubMed ID: 8792681
    [No Abstract]   [Full Text] [Related]  

  • 18. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.
    Goenka MK; Kochhar R; Tandia B; Mehta SK
    Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?].
    Moum B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of hemophagocytic syndrome in an ulcerative colitis patient].
    Kim YC; Kim GM; Lee HS; Hong SI; Cheung DY; Kim JI; Park SH; Kim JK
    Korean J Gastroenterol; 2010 Jul; 56(1):45-8. PubMed ID: 20695130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.